InNexus Biotechnology, Inc.
IXSBF · OTC
6/30/2010 | 6/30/2009 | 6/30/2008 | 6/30/2007 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | -93.4% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | -60,403.4% | -1,583.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -515,888.8% | -35,991.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -582,934.9% | -33,861.5% |
| EPS Diluted | -0.07 | -0.11 | -0.11 | -0.13 |
| % Growth | 36.4% | 0% | 15.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |